Log in to save to my catalogue

Castration-Resistant Prostate Cancer: Targeted Therapies

Castration-Resistant Prostate Cancer: Targeted Therapies

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_citationtrail_10_1159_000323581

Castration-Resistant Prostate Cancer: Targeted Therapies

About this item

Full title

Castration-Resistant Prostate Cancer: Targeted Therapies

Publisher

Basel, Switzerland: S. Karger AG

Journal title

Chemotherapy (Basel), 2011-01, Vol.57 (2), p.115-127

Language

English

Formats

Publication information

Publisher

Basel, Switzerland: S. Karger AG

More information

Scope and Contents

Contents

Background: Castration-resistant prostate cancer (CRPC) refers to patients who no longer respond to surgical or medical castration. Standard treatment options are limited. Objective: To review the concepts and rationale behind targeted agents currently in late-stage clinical testing for patients with CRPC. Methods: Novel targeted therapies in clini...

Alternative Titles

Full title

Castration-Resistant Prostate Cancer: Targeted Therapies

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_citationtrail_10_1159_000323581

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_citationtrail_10_1159_000323581

Other Identifiers

ISSN

0009-3157,1421-9794

E-ISSN

1421-9794

DOI

10.1159/000323581

How to access this item